Mengniu emerge as a pioneer in developing nutritional ingredients, particularly through groundbreaking advancements in HMO technology In August 2024, Synaura Biotechnology a subsidiary of China Mengniu Dairy Company Limited, received GRAS certification from the U.S. Food and Drug Administration (FDA) for its 2′-FL (2′-Fucosyllactose), making it the first and only[Read More…]